{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T04:49:13Z","timestamp":1781498953987,"version":"3.54.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2002,1,1]],"date-time":"2002-01-01T00:00:00Z","timestamp":1009843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2002,1,1]],"date-time":"2002-01-01T00:00:00Z","timestamp":1009843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2002,1]]},"DOI":"10.1124\/jpet.102.042754","type":"journal-article","created":{"date-parts":[[2003,1,10]],"date-time":"2003-01-10T18:49:58Z","timestamp":1042224598000},"page":"1273-1282","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":116,"title":["Nitric Oxide-Donating Nonsteroidal Anti-Inflammatory Drugs Inhibit the Growth of Various Cultured Human Cancer Cells: Evidence of a Tissue Type-Independent Effect"],"prefix":"10.1016","volume":"303","author":[{"given":"Khosrow","family":"Kashfi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaser","family":"Rayyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon L.","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennie L.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero","family":"del Soldato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Traganos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basil","family":"Rigas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.102.042754_bib1","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0026-895X(24)09260-5","article-title":"Cyclooxygenase inhibitors regulate the expression of a TGF-\u03b2 superfamily member that has proapoptotic and antitumorigenic activities.","volume":"59","author":"Baek","year":"2001","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.102.042754_bib2","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1124\/jpet.301.3.1126","article-title":"Dual function of nonsteroidal anti-inflammatory drugs (NSAIDs): inhibition of cyclooxygenase and induction of NSAID-activated gene.","volume":"301","author":"Baek","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.102.042754_bib3","doi-asserted-by":"crossref","first-page":"L367","DOI":"10.1016\/S0024-3205(98)00191-X","article-title":"Cyclooxygenase-independent chemoprevention with an aspirin derivative in a rat model of colonic adenocarcinoma.","volume":"62","author":"Bak","year":"1998","journal-title":"Life Sci"},{"key":"10.1124\/jpet.102.042754_bib4","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/0016-5085(94)90246-1","article-title":"Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas.","volume":"107","author":"Eberhart","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1124\/jpet.102.042754_bib5","article-title":"Gastrointestinal safety of a NO-releasing aspirin derivative (NCX 4016) in humans: a double blind placebo controlled endoscopic study.","volume":"122","author":"Fiorrucci","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1124\/jpet.102.042754_bib6","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S0014-5793(97)00544-9","article-title":"Exogenous, but not endogenous, nitric oxide increases proliferation rates in senescent human fibroblasts.","volume":"410","author":"Gansauge","year":"1997","journal-title":"FEBS Lett"},{"key":"10.1124\/jpet.102.042754_bib7","first-page":"611","article-title":"Nitric oxide-induced apoptosis in human pancreatic carcinoma cell lines is associated with a G1-arrest and an increase of the cyclin-dependent kinase inhibitor p21WAF1\/CIP1.","volume":"9","author":"Gansauge","year":"1998","journal-title":"Cell Growth Differ"},{"key":"10.1124\/jpet.102.042754_bib8","doi-asserted-by":"crossref","first-page":"A478","DOI":"10.1016\/0016-5085(95)26228-8","article-title":"NSAIDs inhibit the growth of colon cancer cell lines by a prostaglandin independent pathway.","volume":"108","author":"Hanif","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1124\/jpet.102.042754_bib9","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1002\/cncr.10262","article-title":"Expression of cyclooxygenase-1 and cyclooxygenase-2 in bronchial epithelium and nonsmall cell lung carcinoma.","volume":"94","author":"Hasturk","year":"2002","journal-title":"Cancer"},{"key":"10.1124\/jpet.102.042754_bib10","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0090-6980(02)00003-5","article-title":"Colon cancer prevention with NO-releasing NSAIDs.","volume":"67","author":"Kaza","year":"2002","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1124\/jpet.102.042754_bib11","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1007\/PL00000723","article-title":"Nitric oxide can inhibit apoptosis or switch it into necrosis.","volume":"57","author":"Melino","year":"2000","journal-title":"Cell Mol Life Sci"},{"key":"10.1124\/jpet.102.042754_bib12","first-page":"4356","article-title":"Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: growth inhibition by nonsteroidal anti-inflammatory drugs.","volume":"59","author":"Molina","year":"1999","journal-title":"Cancer Res"},{"key":"10.1124\/jpet.102.042754_bib13","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1042\/bj3100853","article-title":"Insulin regulates enzyme activity, malonyl-CoA sensitivity and mRNA abundance of hepatic carnitine palmitoyltransferase-I.","volume":"310","author":"Park","year":"1995","journal-title":"Biochem J"},{"key":"10.1124\/jpet.102.042754_bib14","first-page":"M69","article-title":"Cyclooxygenase-2 and carcinogenesis.","volume":"1470","author":"Prescott","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/jpet.102.042754_bib15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0006-2952(97)00400-0","article-title":"Effect of aspirin on induction of apoptosis in HT-29 human colon adenocarcinoma cells.","volume":"55","author":"Qiao","year":"1998","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.102.042754_bib16","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/(SICI)1097-0215(19980330)76:1<99::AID-IJC16>3.0.CO;2-B","article-title":"Sulindac sulfide alters the expression of cyclin proteins in HT-29 colon adenocarcinoma cells.","volume":"76","author":"Qiao","year":"1998","journal-title":"Int J Cancer"},{"key":"10.1124\/jpet.102.042754_bib17","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/978-1-4615-4149-3_13","article-title":"Nonsteroidal anti-inflammatory drugs (NSAIDs), cyclooxygenases and the cell cycle. Their interactions in colon cancer.","volume":"470","author":"Rigas","year":"1999","journal-title":"Adv Exp Med Biol"},{"key":"10.1124\/jpet.102.042754_bib18","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1054\/mehy.1999.0023","article-title":"Is inhibition of cyclooxygenase required for the chemopreventive effect of NSAIDs in colon cancer? A model reconciling the current contradiction.","volume":"54","author":"Rigas","year":"2000","journal-title":"Med Hypotheses"},{"key":"10.1124\/jpet.102.042754_bib19","first-page":"885","article-title":"NO-releasing NSAIDs and colon cancer chemoprevention: a promising novel approach (Review).","volume":"20","author":"Rigas","year":"2002","journal-title":"Int J Oncol"},{"key":"10.1124\/jpet.102.042754_bib20","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1172\/JCI118060","article-title":"Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence and induces apoptosis in HT-29 colon adenocarcinoma cells.","volume":"96","author":"Shiff","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.102.042754_bib21","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/jnci\/94.4.252","article-title":"Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic and clinical issues.","volume":"94","author":"Thun","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1124\/jpet.102.042754_bib22","first-page":"3285","article-title":"Nitric oxide-releasing nonsteroidal anti-inflammatory drugs (NSAIDs) alter the kinetics of human colon cancer cell lines more effectively than traditional NSAIDs: implications for colon cancer chemoprevention.","volume":"61","author":"Williams","year":"2001","journal-title":"Cancer Res"}],"updated-by":[{"DOI":"10.1016\/s0022-3565(24)30814-6","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2003,7,1]],"date-time":"2003-07-01T00:00:00Z","timestamp":1057017600000}},{"DOI":"10.1016\/s0022-3565(24)31025-0","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2003,11,1]],"date-time":"2003-11-01T00:00:00Z","timestamp":1067644800000}},{"DOI":"10.1124\/jpet.117.42754err","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000}}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524360653?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524360653?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.102.042754","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T23:32:57Z","timestamp":1740007977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524360653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,1]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,1]]}},"alternative-id":["S0022356524360653"],"URL":"https:\/\/doi.org\/10.1124\/jpet.102.042754","relation":{"erratum":[{"id-type":"doi","id":"10.1124\/jpet.117.42754err","asserted-by":"object"},{"id-type":"doi","id":"10.1016\/S0022-3565(24)30814-6","asserted-by":"object"},{"id-type":"doi","id":"10.1016\/S0022-3565(24)31025-0","asserted-by":"object"}]},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2002,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nitric Oxide-Donating Nonsteroidal Anti-Inflammatory Drugs Inhibit the Growth of Various Cultured Human Cancer Cells: Evidence of a Tissue Type-Independent Effect","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.102.042754","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2002 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}